Araceli Biosciences, founded in 2019 in Tigard, Oregon, began its journey with a bold vision: to streamline and accelerate drug discovery through cutting-edge imaging-based technologies. By emphasizing rapid data acquisition and robust analytics, Araceli has quickly gained traction with organizations seeking innovative solutions to clarify complex biological processes. Working hand in hand with life sciences partners, the company has leveraged its seed funding to expand operational capabilities and cement a strong market presence in biotech.
Araceli continues to refine its proprietary platforms, forging strategic partnerships and staying on the leading edge of research and development. Their high-throughput imaging solutions simplify the path from early-stage discovery to actionable insights, making them indispensable to biopharma companies, academic research institutions, and biotech innovators. Delivering clarity in the most complex cellular landscapes underscores their commitment to elevating scientific clarity, speed, and accuracy. With an unwavering focus on scalable technology, customer-centric support, and groundbreaking research collaborations, Araceli is charting a clear path toward industry leadership.
